UT Health develops drug that doubles survival for glioblastoma patients

Link to primary manuscript: https://www.nature.com/articles/s41467-025-57263-1

Caveat: Single-arm Phase 1 trial of just 21 patients.

Graphical abstract in the supplementary materials: https://static-content.springer.com/esm/art%3A10.1038%2Fs414...